AIAnak Agung Gede Indraningrat

Anak Agung Gede Indraningrat

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anak Agung Gede Indraningrat has a total of 67 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cytotoxic and Apoptosis-Associated Activity of Schefflera elliptica (Blume) Harms Ethanolic Extract in T47D Breast Cancer Cells Supported by LC-HRMS Profiling and Molecular Docking

    by Made Dharmesti Wijaya, Anak Agung Gede Indraningrat, Wirdatun Nafisah, Nora Ertanti

    Breast cancer continues to impose a substantial global health burden, and natural products remain an important source of candidates for anticancer research. This study investigated the cytotoxic and apoptosis-associated effects of the ethanolic extract of Schefflera elliptica against T47D human breast cancer cells. Cytotoxicity was evaluated using the MTT assay, while apoptosis-associated responses were assessed by Annexin V-FITC/propidium iodide flow cytometry and caspase-3 and caspase-8 immunofluorescence. Metabolite profiling was performed using liquid chromatography–high-resolution mass spectrometry (LC-HRMS), followed by exploratory molecular docking of selected metabolites against the anti-apoptotic protein Bcl-2. The crude ethanolic extract exhibited moderate cytotoxic activity, with an IC50 of 339 μg/mL. Treatment increased the Annexin V-positive cell population, with significant increases observed at 160 and 320 μg/mL, and was accompanied by increased caspase-3 and caspase-8 immunofluorescence signals. LC-HRMS profiling yielded 39 putatively annotated metabolites, with choline, L-norleucine, and valine among the most abundant. Molecular docking predicted interactions of these metabolites within the Bcl-2 binding pocket, although their predicted binding affinities were weaker than those of venetoclax. Overall, the findings indicate that S. elliptica ethanolic extract exhibits moderate cytotoxic activity accompanied by apoptosis-associated cellular responses in T47D cells. The integrated biological, metabolomic, and computational findings provide a basis for further bioactivity-guided investigation of the active constituents and their underlying mechanisms.

  • Open Access

    Potent Antioxidant and Antibacterial Activities of Muntingia calabura Leaf Extract: A Natural Defence Against MDR Bacteria

    by Anak Agung Gede Indraningrat, Pande Putu Christine Putri Purnami, Ketut Agus Yogi Indrawan, Ni Made Ayu Suardani Singapurwa, Made Dharmesti Wijaya, Desak Putu Oki Lestari, Geok Yuan Annie Tan

    Muntingia calabura has long been used in traditional medicine for its antioxidant and antimicrobial benefits, yet scientific validation of its ethyl acetate leaf extract, particularly against multidrug-resistant (MDR) bacteria, remains limited. This study assessed the phytochemical profile, antioxidant potential, and antibacterial efficacy of the ethyl acetate leaf extract of M. calabura. Qualitative phytochemical screening revealed the presence of flavonoids, tannins, saponins, and steroids. Antioxidant evaluation using the DPPH assay demonstrated very strong radical-scavenging activity, with an IC₅₀ value of 37.32 ppm. Antibacterial testing showed clear inhibitory effects against standard pathogenic strains, with the strongest activity observed against Streptococcus mutans (13.04±2.03 mm), followed by Escherichia coli and Staphylococcus aureus. The extract also exhibited measurable activity against clinically relevant MDR isolates, including ESBL-producing E. coli (8.01±0.10 mm), Klebsiella pneumoniae (7.8±0.5 mm), and Acinetobacter baumannii (8.3±0.2 mm). GC/MS profiling identified 64 compounds, with δ-tocopherol, a chromenone derivative, and a benzopyran analog as the most abundant constituents known for antioxidant and antibacterial properties. Collectively, these findings provide scientific support for the ethnomedicinal use of M. calabura and highlight its potential as a natural source of bioactive compounds active against both standard and MDR bacteria.

  • Open Access

    GAS CHROMATOGRAPHY-MASS SPECTROMETRY (GC-MS) PROFILING AND ANTIBACTERIAL ACTIVITY OF SECONDARY METABOLITES PRODUCED BY Bacillus sp. SA11 FROM MANGROVE SOIL

    by Ni Kadek Widya Diari Ningsih, Anak Agung Gede Indraningrat, Anak Agung Ayu Lila Paramasatiari, Daegeun Choe

    Background: Bacterial infections are a major global health concern, including in Indonesia. This has led to an increased effort to find new antibacterial compounds in natural resources. Bacillus sp. SA11, with reported antibacterial potential, was previously isolated from mangrove soil in Denpasar, Bali. This study further investigated its antibacterial activity.Methods: Secondary metabolites were extracted from Bacillus sp. SA11 liquid culture using ethyl acetate. The extract was then screened for antibacterial activity against Escherichia coli ATCC 25922, Streptococcus mutans FNCC 0405, Staphylococcus aureus ATCC 25923, and Klebsiella pneumoniae ATCC 70060 using the Kirby-Bauer method (three replicates). The chemical composition of the extract was analysed via GC-MS.Results: The ethyl acetate extract showed inhibition zones for E. coli, S. mutans, S. aureus, and K. pneumoniae of 11.7 ± 1.11 mm, 10.22 ± 1.5 mm, 8.7 ± 0.94 mm, and 7.2 ± 0.67 mm, respectively. GC/MS analysis identified 165 compounds, 20 of them have been previously linked to antibacterial activities. The five most abundant compounds are n-hexadecanoic acid (6.91%), 2-butoxyethyl acetate (6.3%), Bis(2-ethylhexyl) phthalate (4.45%), Phthalic acid, di(2-propylpentyl) ester (4.45%) and Benzene, 1,3,5-trimethyl- (Mesitylene).Conclusion: These findings provide preliminary evidence that Bacillus sp. SA11, isolated from the mangrove ecosystem, has the potential to produce antibacterial compounds.

  • Open Access

    BACILLUS SP RM3 ISOLATED FROM MANGROVE FOREST HAS POTENTIAL AS ANTIBACTERIAL ACTIVITY AND CYTOTOXICITY

    by Ida Ayu Kartika Maheswari, Anak Agung Gede Indraningrat, Anak Agung Ayu Lila Paramasatiari, Daegeun Choe

    Background: Antibacterial resistance is a critical health concern, driving the search for new compounds from natural sources such as mangrove-associated bacteria, which produce diverse secondary metabolites.Objective: This research focused on studying the bioactivity of the extract of Bacillus sp. RM3, previously isolated from mangrove forests through an extraction method using ethyl acetate solvent.Methods: The Bacillus sp. RM3 isolate was fermented in ISP-2 media and extracted with ethyl acetate. The resulting crude extract was tested for antibacterial activity using the Kirby-Bauer method against Staphylococcus aureus ATCC 25923, Streptococcus mutans FNCC 0405 (Gram-positive), Escherichia coli ATCC 25922, and Klebsiella pneumoniae ATCC 700603 (Gram-negative). Cytotoxic effects were assessed via the Brine Shrimp Lethality Assay (BSLT).Results: The ethyl acetate extract displayed moderate antibacterial activity, evidenced by inhibition zone diameters between 5 to 10 mm. Triplicate measurements revealed the following average inhibition zone diameters: E. coli (9.65±1.62 mm), K. pneumoniae (7.88±1.92 mm), S. aureus (7.77±1.26 mm), and S. mutans (7.03±0.99 mm). Furthermore, the BSLT assay revealed an LC50 value of 504.586 ppm, which indicates the extract was toxic (LC50 1000 ppm).Conclusions: Overall, these results indicate the potential of Bacillus sp. RM3 isolate as a producer of antibacterial and cytotoxic compounds


  • Open Access

    ANTIBACTERIAL ACTIVITY SCREENING OF BACTERIAL ISOLATES ASSOCIATED WITH SEAWEEDS Caulerpa lentillifera

    by Sunthio Barran Cia Ar, Anak Agung Gede Indraningrat, Ni Wayan Widhidewi, Made Dharmesti Wijaya, Kadek Lila Antara, Daegeun Choe

    Background: Caulerpa lentillifera is a species of green algae that has been cultivated widely in Indonesia for its nutritional contents and health benefit. This seaweed builds a strong association with bacterial community which play an important role in synthesizing various secondary metabolites including antibacterial activity. Aims:The research aim to explore the symbiotic relationship between C. lentillifera and its associated bacterial community, focusing on the potential of these bacteria to produce antibacterial metabolites.Methods:Bacterial cultivation was performed on three different media namely nutrient agar, plate count agar, and zobell marine agar. The obtained bacterial isolates were identified morphologically and subsequently were screened for their antibacterial activity based on perpendicular cross streak method against Staphylococcus aureus ATCC 25923, Streptococcus mutans FNCC 0405, Escherichia coli ATCC 25922, and Klebsiella pneumoniae ATCC 700603. Results: 20 out of 28 bacterial isolates inhibited against at least one of the bacterial targets. Bacterial isolate encoded as NAR9 showed as the most promising bacterial isolates with length inhibition of 19 mm against S. mutans FNCC 0405. Amplification of 16S rRNA gene fragment of the NAR9 bacterial isolate followed by Sanger sequencing showed that the isolate NAR9 has been phylogenetically related to Marinobacter hydrocarbonoclasticus. Conclusion: Overall, this research provides a preliminary result of the untapped potential of bacteria associated with C. lentillifera as the source of antibacterial activity.


  • Open Access

    Schefflera eliptica Leaf Extract as Antibiofilm Agent Against the Clinical Isolates of Staphylococcus aureus in Wound, Blood, and Sputum

    by Marta Setiabudy, Anak Agung Gede Indraningrat, Kadek Suryawan, Ni Wayan Widhidewi, Anak Agung Ayu Lila Paramasatiari, Made Dharmesti Wijaya, Putu Indah Budi Apsari, Putu Arya Suryanditha

    Schefflera elliptica leaves contain secondary metabolites such as flavonoids, tannins, and saponins that have the potential as antibiofilm agents. Biofilms produced by Staphylococcus aureus are often the cause of chronic infections, especially on wounds and medical devices such as catheters. Antibiofilm activity of plant extracts is promising as an adjuvant or alternative therapy. The purpose of this study was to determine the antibiofilm activity of ethyl acetate extract of S. elliptica leaf against clinical isolates of S. aureus. This study is an analytical study with a laboratory experimental design to determine antibiofilm activity. The research samples were 18 clinical isolates of S. aureus obtained from patients undergoing examination at the hospital from June 2022 to December 2022. The research was carried out using the stages of sample preparation, extract preparation, biofilm assay with microtiter plate, and antimicrobial test with disc diffusion test method. The results of this study showed that the extract of S. elliptica leaf was able to reduce the average biofilm formation by clinical isolates of S. aureus significantly (p<0.001), both at doses of 10 µL (reduced by 12%) and 20 µL (reduced by 56.7%). Despite having antibiofilm activity, a disc diffusion test with a dose of 20 ul extract of S. elliptica leaf showed no or minimal antimicrobial activity against clinical isolates of S. aureus. Overall, the results of this study indicate that the extract of S. elliptica leaf has the potential as an antibiofilm agent against S. aureus. The results of this study are expected to be the basis of further research for the development of antibiofilm from natural materials.


  • Open Access

    Antibacterial Potential of Pseudomonas aeruginosa ISP1RL4 Isolated from Seaweed Eucheuma cottonii Against Multidrug-resistant Bacteria

    by Anak Agung Gede Indraningrat, Pande Putu Christine Putri Purnami, Ema Damayanti, Made Dharmesti Wijaya, Dewa Ayu Putri Sri Masyeni, Ni Luh Putu Eka Kartika Sari

    Eucheuma cottonii is a type of seaweed that are commonly found in Indonesia. As many other marine organisms, E. cottonii builds a strong bonding with its endophytic bacteria. These bacteria are well known to synthesize various of bioactive compounds including antibacterial compounds to protect its host from bacterial infections and pathogenic bacteria. Previous study has successfully isolated bacterial encoded ISP1RL4 with antibacterial potential against nonresistant Gram-positive and Gram-negative bacterial target. This research aimed to identify the ISP1RL4 isolate based on DNA sequencing, to evaluate antibacterial activity of the crude extract of ISP1RL4 isolate against multidrug-resistant bacterial target and to analysis chemical profiling of the extracts. Briefly, the cell mass of ISP1RL4 bacterial isolate was fermented for 2 weeks in 100 mL sterile liquid ISP-2 medium and then filtered. Extraction was carried out using ethyl acetate with an extraction ratio of 1:1 twice. Ethyl acetate extracts of ISP1RL4 were tested against multidrug-resistant bacteria Methicilin-resistant Staphylococcus aureus (MRSA), Escherichia coli ESBL, Klebsiella pneumoniae ESBL, and Acinetobacter baumanii. Our findings revealed that the ISP1RL4 phylogenetically related to Pseudomonas aeruginosa strain M4 with 100% of sequence similarity. The crude extract of P. aeruginosa ISP1RL4 showed diameter zone of inhibition of 9.0±1.0 mm, 10.3±2.0 mm and 9.4±0.1 mm against MRSA, E. coli ESBL, and K. pneumoniae ESBL respectively. No antibacterial activity of the crude extract was observed against A. baumanii. The liquid chromatography-high resolution mass spectrometry (LC-HRMS) analysis detected 381 compounds with 2-Amino-1,3,4-octadecanetriol (11.2%) identified as the major antibacterial compound present in ethyl acetate extracts of P. aeruginosa ISP1RL4. In addition, gas chromatography/mass spectrometry (GC/MS) analysis identified 39 compounds and 11 of them have been associated as antibacterial molecules. Among these 11 molecules, four prominent antibacterial compounds (> 8%) were 2-hexanol, 3-hexanol, 3-Pentanol, 2-methyl- and 2-hexanone. Overall, the ability of P. aeruginosa ISP1RL4 crude extract to inhibit selected multidrug-resistant bacterial target and the presence antibacterial compounds in the extract provided a promising result that the isolate could potentially be a promising antibacterial producer.


  • Open Access

    Phytochemical and Toxicity Analysis of Sonneratia alba Mangrove Leaf Extract using the Brine Shrimp Lethality Test (BSLT) Method

    by Ni Kadek Dewi Asri Tiara Arta, Anak Agung Gede Indraningrat, Made Dharmesti Wijaya

    Mangroves are plants that contain various secondary metabolites with various potential pharmacological activities, one of which is cytotoxic activity. However, researchers have not extensively explored the evidence of secondary metabolite compounds and their toxicity effects in mangrove plants. This research aims to determine the content of secondary metabolite compounds and the toxicity of the leaf extract of the Sonneratia alba mangrove plant in the Ngurah Rai Grand Forest Park (TAHURA), Bali. In this experimental research, compound extraction was carried out using a maceration technique for 2x24 hours using two types of solvents, namely methanol and n-hexane. Phytochemical tests were carried out using qualitative methods and gas chromatography-mass spectrometry (GC-MS), while the toxicity test used was the brine shrimp lethality test (BSLT) method. Potassium dichromate and sea water without extract were used as positive and negative controls, respectively. The LC50 value was calculated using probit analysis in Microsoft Excel. Phytochemical test results showed that the methanol extract contains phenol, saponin, tannin, and steroid compounds. Meanwhile, n-hexane extract only contains steroid compounds. GC-MS analysis showed that the compounds with the largest area percentages in the methanol and n-hexane extracts were 1,2,3-benzenetriol (3.94%) and n-hexadecenoic acid (2.41%), respectively. Based on the LC50 value, the methanol extract of S. alba mangrove leaves was moderately toxic (178.17 ppm), while the n-hexane extract was weakly toxic (567.23 ppm). The results of this study provide information that the type of chemical solvent has a major influence on the level of toxicity of S. alba leaf extract, with polar methanol solvent providing the highest toxicity effect compared to nonpolar n-hexane solvent.


  • Open Access

    Antibacterial Activity Screening of Bacillus sp. AM12 Associated with Mangrove Soil

    by Evellyne Natania, Anak Agung Gede Indraningrat, Ni Wayan Widhidewi

    The use of synthetic antibiotics to treat bacterial infections can trigger resistance of pathogenic bacteria to antibiotics. One effort to overcome this is to explore microorganisms that produce antibacterial compounds from nature. A previous study reported isolates of Bacillus sp. AM12 from mangrove soil displayed antibacterial potential based on preliminary screening of the perpendicular streak test. This study was designed to confirm the antibacterial potential of Bacillus sp. AM12 uses chemical solvent extraction. Bacillus sp. AM12 was fermented in 100 mL liquid ISP-2 sterile and shaken at 150 rpm for 7 days. The supernatant was filtered from the cell mass using Whatman paper and extracted using 100 mL of ethyl acetate solvent (1:1, v/v) twice. The filtrate was evaporated at 40ºC until a thick, clear yellowish colored extract was obtained. The thick extract was tested for antibacterial activity using the Kirby-Bauer method against two Gram positive and two Gram negative bacterial targets. Antibacterial screening showed moderate diameter zone of inhibition of 6.72 ± 0.21 mm, 6.82 ± 0.15 mm, and 6.62 ± 0.21 mm against Staphylococcus aureus ATCC 25923, Streptococcus mutans FNCC 0405, and Klebsiella pneumoniae ATCC 70060, respectively. However, no antibacterial activity was observed against Escherichia coli ATCC 25922. Analysis of the chemical composition of ethyl acetate crude extracts using GC-MS has detected 10 different compounds, in which the 3 most dominant antibacterial compounds were Benzene, 1,2,4-Trimethyl-, Benzene, 1-ethyl-2-methyl- and 2-butoxyethyl acetate. In general, these results provide an initial description of Bacillus sp. AM12 is a potential of antibacterial producer.


  • Open Access

    Biofilm Formation in Staphylococcus aureus and Coagulase-Negative Staphylococcus

    by Marta Setiabudy, Dewa Ayu Putri Sri Masyeni, Anak Agung Gede Indraningrat, Kadek Suryawan, I Ketut Agus Indra Adhiputra, Muhammad Amirul bin Abdul Rahman

    Highlights: 1. The significance of Staphylococcus aureus and coagulase-negative Staphylococcus, which are more likely to infect immunocompromised patients, needed to be researched in greater depth. 2. Coagulase-negative Staphylococcus was found to form significantly more biofilm than Staphylococcus aureus. 3. Wound care and changing medical devices in immunocompromised patients on a regular basis may provide benefits to prevent biofilm formation by Staphylococcus spp. Abstract Staphylococcus spp. are typically commensal microorganisms that can exist in the human body without causing illness. However, these bacteria have virulence factors, e.g., biofilm formation, that are important to note. Because biofilms shield bacteria from opsonophagocytosis and antimicrobial agents, they can cause persistent or chronic infections. Once they form biofilms, both Staphylococcus aureus and coagulase-negative Staphylococcus (CoNS) can potentially cause incurable infections. This study aimed to compare biofilm formation in Staphylococcus aureus and coagulase-negative Staphylococcus as a guide for the prevention and management of infection, which will maintain and improve the good health of the general population. This was an analytic research with a cross-sectional design. The study began by collecting the samples, identifying the species, and testing the biofilm production with a microtiter plate, which was then analyzed with an enzyme-linked immunosorbent assay (ELISA). Data analysis was conducted using IBM SPSS Statistics for Windows, version 25.0 (IBM Corp., Armonk, N.Y., USA). Comparison tests were conducted using an independent t-test. A value of pStaphylococcus aureus and 18 coagulase-negative Staphylococcus. The specimens consisted of 20 blood samples (55.6%) and 7 wound swabs (19.4%). The biofilm test on the samples showed that 83.3% of the samples produced biofilms. The data revealed that the isolates formed biofilms, with 14 isolates (38.9%) in the strong category, 10 isolates (27.8%) in the moderate category, and each of 6 isolates (16.7%) in the weak and non-existent categories. Both Staphylococcus spp. appeared to have biofilm-forming activity, but coagulase-negative Staphylococcus appeared to be significantly more dominant (p=0.008). Strong biofilm was produced by 61.1% of coagulase-negative Staphylococcus isolates. In conclusion, coagulase-negative Staphylococcus formed a stronger biofilm than Staphylococcus aureus. Its presence as an infection-causing bacteria, particularly in immunocompromised patients, should not be underestimated.